An electronic newsletter and interim supplement on Japanese encephalitis
JE Newsbriefs is a quarterly electronic newsletter for global health experts. It provides updates on PATH’s work to increase the availability in the developing world of a vaccine against Japanese encephalitis—a mosquito-borne illness that can cause severe neurological disability or death.
JE Flash serves as a supplement between newsletter editions to provide breaking news on Japanese encephalitis disease and vaccines. When you subscribe to JE Newsbriefs, you will also receive occasional JE Flash emails to keep you up to date on the field's latest developments.
Sign up for JE Newsbriefs and JE Flash with a message to jeproject@path.org. Click on the links below to access past issues archived in PATH’s Vaccine Resource Library.
JE Newsbriefs
Sign up for JE Newsbriefs and JE Flash with a message to jeproject@path.org. Click on the links below to access past issues archived in PATH’s Vaccine Resource Library.
- Coalition of partners to maintain momentum of JE control
- CDIBP proceeds with commissioning of new JE vaccine production facility
- Intercell’s IC51 JE vaccine for travelers gains regulatory approvals
- JE Control by 2015 details sustainable priorities for the future
- CDIBP JE vaccine facility nears mechanical completion
- GAVI Alliance commits to seek funding for JE vaccine introduction support
- International symposium presents advances in JE detection and prevention
- Vaccine production facilities unharmed in Chengdu’s major earthquake
- The Lancet article highlights inclusion of JE in GAVI Alliance strategy
- India aims to vaccinate 20 million more in third year of JE immunization strategy
- WHO advisory committee acknowledges safety of coadministering live JE and measles vaccines
- Cohort study assesses WHO JE surveillance standards
- Follow-up study shows long-term protection when measles and JE vaccines are given together
- Groundbreaking ceremony held for new facility at Chengdu Institute
- Studies initiated to advance JE control in Sri Lanka
- Biregional meeting marks progress and maps out next steps
- Study demonstrates long-term protection from single dose of SA 14-14-2 JE vaccine
- India and Nepal expand JE vaccination campaigns
- JE immunization highlighted at Global Vaccine Research Forum
- WHO/SEARO issues guidelines on SA 14-14-2 vaccine introduction
- Partner profile: Center for Vaccine Development, Mahidol University
- India protects 9 million children against JE
- Nepal safeguards 2 million children
- WHO updates position paper on JE vaccines
- Partner profile: Technip
- SEARO laboratory network established
- India approves licensure of SA 14-14-2 vaccine
- Public-sector pricing established
- Strategic Advisory Group of Experts addresses JE control through immunization
- JE Project-supported studies
- JE outbreak in India
- WHO committee reviews safety and efficacy of SA 14-14-2 vaccine
- JE control highlighted in BBC World documentary
- New JE e-learning tool on web and CD-ROM
- Nepal prepares the way for better JE control
- Partner profile: AFRIMS in Thailand
- JE on the move
- Interactive JE reporting system to debut in India
- Indonesia plans first nationwide assessment of JE
- The JE Core Working Group
JE Flash
Sign up for JE Newsbriefs and JE Flash with a message to jeproject@path.org. Click on the links below to access past issues archived in PATH’s Vaccine Resource Library.
December 14, 2006
Independent review of adverse events following JE immunization in India
November 14, 2006
Study finds JE and measles vaccines can be given together without interference